Oramed Pharmaceuticals (ORMP) Asset Writedowns and Impairment (2012)
Oramed Pharmaceuticals (ORMP) reported Asset Writedowns and Impairment of $141143.0 for Q3 2012, up 227.39% quarter-over-quarter from $43111.0 in Q1 2012.
Oramed Pharmaceuticals (ORMP) Asset Writedowns and Impairment (2012) Analysis & Trends
Oramed Pharmaceuticals has reported Asset Writedowns and Impairment for 1 years, with the latest figure at $141143.0 in Q3 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Oramed Pharmaceuticals | 151.47 Mn | 133.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2012 | 141,143.00 |
| Aug 31, 2012 | 141,143.00 |
| Feb 29, 2012 | 43,111.00 |
| Feb 29, 2012 | 43,111.00 |